(Q45238420)

English

Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

0 references

author name string

Masamichi Takami

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Eun Sook Cho

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Soo Young Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Ryutaro Kamijo

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Mijung Yim

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

579

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

832-838

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Osteoblastic cells are involved in osteoclast formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Molecular diversity of cyclic AMP signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Cyclic nucleotide phosphodiesterases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Involvement of phosphodiesterase isozymes in osteoblastic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.12.066

21 January 2018

Identifiers

10.1016/J.FEBSLET.2004.12.066

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45238420&oldid=2070961401"